REGULATED INFORMATION
November 19, 2024, 7:00am CET / 1:00am ET
NYXOAH SA
(Euronext Brussels/Nasdaq: NYXH)
Rue Edouard Belin 12, 1435 [...] Read more »
REGULATED INFORMATION
November 19, 2024, 7:00am CET / 1:00am ET
NYXOAH SA
(Euronext Brussels/Nasdaq: NYXH)
Rue Edouard Belin 12, 1435 [...] Read more »
REGULATED INFORMATION
Publication relating to transparency notifications
Read more »
BRIDGEWATER, New Jersey, 12 nov. 2024 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (« Synchronoss » ou la « Société ») (NASDAQ : SNCR), un innovateur [...] Read more »
BRIDGEWATER, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — A Synchronoss Technologies, Inc. (“Synchronoss” ou a “Empresa”) (Nasdaq: SNCR), líder global e inovadora em plataformas de nuvens [...] Read more »
BRIDGEWATER, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. („Synchronoss“ oder das „Unternehmen“) (NASDAQ: SNCR), ein weltweit führender Anbieter und Innovator im [...] Read more »
BRIDGEWATER, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (NASDAQ: SNCR), a global leader and innovator in personal cloud platforms, today [...] Read more »
JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptides and small therapeutic proteins, today [...] Read more »
WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical–stage global biopharmaceutical company committed to being a [...] Read more »
INFORMATIONS RÉGLEMENTÉES
Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le [...] Read more »
REGULATED INFORMATION
Nyxoah Reports Third Quarter Financial and Operating [...] Read more »